Sapan Gai, CCO at Sovereign Metals, discusses their superior graphite test results. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.099
Bid: 0.0972
Ask: 0.102
Change: 0.00 (0.00%)
Spread: 0.0048 (4.938%)
Open: 0.099
High: 0.00
Low: 0.00
Prev. Close: 0.099
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Placing to raise £400,000

19 Jan 2024 07:00

RNS Number : 2199A
Versarien PLC
19 January 2024
 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF THE MARKET ABUSE REGULATION (EU) 596/2014 (AS AMENDED) AS IT FORMS PART OF THE DOMESTIC LAW OF THE UNITED KINGDOM BY VIRTUE OF THE EUROPEAN UNION (WITHDRAWAL) ACT 2018 (AS AMENDED). UPON PUBLICATION OF THIS ANNOUNCMENT, THIS INSIDE INFORMATION IS NOW CONSIDERED TO BE IN THE PUBLIC DOMAIN.

 

19 January 2024

 

Versarien plc

 

("Versarien" or the "Company")

 

Placing to raise £400,000

 

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has raised £400,000 (before expenses) by way of a placing (the "Placing") of 500,000,000 new ordinary shares in the capital of the Company ("Placing Shares") at a price of 0.08 pence per share (the "Placing Price").

 

Highlights

 

· Versarien has raised £400,000, before expenses, through the placing of 500,000,000 new ordinary shares in the capital of the Company at a price of 0.08 pence per share

· The net proceeds of the Placing will be used for corporate and working capital purposes as the Company seeks to capitalise on the growing number of opportunities in its pipeline whilst continuing to progress its asset sales

· The issue of the Placing Shares is within existing authorities granted by shareholders at the general meeting of the Company held on 10 January 2024 and therefore no shareholder approval is required for the Placing

 

Use of Proceeds and Turnaround Strategy

 

The net proceeds of the Placing will be used for corporate and working capital purposes as the Company seeks to capitalise on the growing number of opportunities in its pipeline. Recent new projects include a sales agreement with Go To Gym to bring Graphene-WearTM products to Colombia, Brazil and the USA, and Versarien's subsidiary, Gnanomat, entering into an agreement to co-develop advanced materials with IRPC, a Thai petroleum and petrochemical company. These projects, along with a pipeline of other opportunities currently being pursued demonstrate the longer term prospects for the business.

 

As announced on 20 December 2023, the mature businesses and the intellectual property and plant acquired from Hanwha Aerospace in 2020 continue to be marketed for sale and the Company is progressing discussions with a number of interested parties, though the timing of any asset sales and the quantum of the funds that may be received remains uncertain.

 

Stephen Hodge, Chief Executive Officer of Versarien, commented:

 

"In the short time since the Company Update announced on 20 December, the commercial, licencing and grant opportunities have continued to grow. This further funding will help us to progress the conversion of these leads while the asset sale discussions continue. We look forward to updating the market in due course."

 

Admission and Total Voting Rights

 

Application has been made for admission of the Placing Shares to be admitted to trading on AIM ("Admission") on or around 24 January 2024. The Placing Shares will rank pari passu in all respects with the Company's existing ordinary shares. Following Admission, the total number of ordinary shares in the Company in issue will be 996,169,507. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in the Company under the FCA's Disclosure and Transparency Rules.

 

For further information please contact:

 

Versarien

Stephen Hodge, Chief Executive Officer

Chris Leigh, Chief Financial Officer

 

c/o IFC

SP Angel Corporate Finance (Nominated Adviser and Broker)

Matthew Johnson, Adam Cowl

+44 (0)20 3470 0470

 

 

IFC Advisory Limited (Financial PR and Investor Relations)

Tim Metcalfe, Zach Cohen

+44 (0) 20 3934 6630

 

About Versarien:

 

The strategy of Versarien plc (AIM:VRS) is to be a development led advanced materials company focussed on specific sectors that will lead to a light manufacturing and licensing model.

 

For further information please see: http://www.versarien.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEGPUGWGUPCPGR
Date   Source Headline
3rd Nov 20174:40 pmRNSTrading Update and Notice of Results
31st Oct 20174:40 pmRNSSecond Price Monitoring Extn
31st Oct 20174:35 pmRNSPrice Monitoring Extension
31st Oct 20172:05 pmRNSSecond Price Monitoring Extn
31st Oct 20172:00 pmRNSPrice Monitoring Extension
31st Oct 20177:00 amRNSCollaboration with Israel Aerospace Industries
2nd Oct 20177:00 amRNSAward of Share Options to Directors
22nd Sep 20171:11 pmRNSDirector/PDMR Shareholding
21st Sep 20179:38 amRNSHolding(s) in Company
20th Sep 20179:00 amRNSHolding(s) in Company
19th Sep 201711:01 amRNSHolding(s) in Company
19th Sep 201711:00 amRNSHolding(s) in Company
19th Sep 20177:00 amRNSSignificant Tender Win
14th Sep 20176:03 pmRNSHolding(s) in Company
13th Sep 201711:45 amRNSResult of AGM
12th Sep 201712:26 pmRNSHolding(s) in Company
12th Sep 20177:00 amRNSHolding(s) in Company
11th Sep 20178:09 amRNSHolding(s) in Company
7th Sep 20177:00 amRNSContract Win
1st Sep 20177:00 amRNSHolding(s) in Company
23rd Aug 20173:45 pmRNSHolding(s) in Company
9th Aug 201710:30 amRNSNotice of AGM
3rd Jul 20177:00 amRNSFinal Results for the year ended 31 March 2017
20th Apr 20177:00 amRNSInvestor Event
20th Apr 20177:00 amRNSResignation of Director
6th Apr 201711:13 amRNSHolding(s) in Company
4th Apr 20173:45 pmRNSHolding(s) in Company
4th Apr 20178:00 amRNSHolding(s) in Company
21st Mar 20177:00 amRNSCambridge Graphene Update
15th Mar 20179:43 amRNSHolding(s) in Company
9th Mar 20171:00 pmRNSHolding(s) in Company
6th Mar 20177:00 amRNSSuccessful Fundraising of £1.5 million
3rd Mar 20174:38 pmRNSFundraising of approximately £1 million
16th Feb 20177:00 amRNSNanene Distribution Agreement
8th Feb 20177:00 amRNSLaunch of Nanene
30th Jan 201710:04 amRNSHolding(s) in Company
19th Jan 20171:21 pmRNSAcquisition and Trading Update
19th Dec 20167:00 amRNSFurther Graphene Enhanced PAEK Plastics Agreement
14th Dec 201610:45 amRNSHolding(s) in Company
14th Dec 20167:00 amRNSGraphene enhanced PAEK Thermoplastics Agreement
29th Nov 20167:01 amRNSInterim Results
29th Nov 20167:00 amRNSSignificant Graphene Order
23rd Nov 20167:00 amRNSNotice of Results
9th Nov 201610:00 amRNSInvestor site visit presentations
31st Oct 20169:15 amRNSDebt for Equity Swap with UoM
27th Oct 20167:00 amRNSNew Healthcare Graphene Project
18th Oct 20167:00 amRNSInvestor Event
13th Oct 20167:00 amRNSCompletion of NGI composite project
3rd Oct 20167:00 amRNSAcquisition of AAC Cyroma
27th Sep 20161:38 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.